Contact
Please use this form to send email to PR contact of this press release:
EyeGate Achieves 75% Enrollment in Pivotal Phase 3 Clinical Trial for Anterior Uveitis Triggering Milestone Payment
TO:
Please use this form to send email to PR contact of this press release:
EyeGate Achieves 75% Enrollment in Pivotal Phase 3 Clinical Trial for Anterior Uveitis Triggering Milestone Payment
TO: